Edition:
United States

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.42USD
4:00pm EDT
Change (% chg)

$-0.04 (-1.63%)
Prev Close
$2.46
Open
$2.46
Day's High
$2.48
Day's Low
$2.42
Volume
1,701
Avg. Vol
129,253
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 0.84
Market Cap(Mil.): $22.84
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.19 -- --
ROI: -11.01 1.96 12.83
ROE: -13.66 1.12 14.95

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $62.03 -0.53

Earnings vs. Estimates